Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in anex vivomodel of donation following circulatory death
Author(s) -
Olivier Van Caenegem,
Christophe Beauloye,
Luc Bertrand,
Sandrine Horman,
Sophie Lepropre,
Grégory Sparavier,
Jonathan Vercruysse,
Noëlla Bethuyne,
Alain Poncelet,
Pierre Gianello,
Peter Demuylder,
E. Legrand,
Gwen Beaurin,
Françoise Bontemps,
Luc Jacquet,
JeanLouis Vanoverschelde
Publication year - 2015
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezv409
Subject(s) - phosphocreatine , ex vivo , contractility , machine perfusion , creatine , energy charge , heart transplantation , transplantation , perfusion , cardiology , viaspan , medicine , in vivo , circulatory system , cold storage , ischemia , adenine nucleotide , chemistry , energy metabolism , biology , biochemistry , receptor , microbiology and biotechnology , horticulture , adenylate kinase , liver transplantation , nucleotide , gene
Cardiac transplantation using hearts from donors after circulatory death (DCD) is critically limited by the unavoidable warm ischaemia and its related unpredictable graft function. Inasmuch as hypothermic machine perfusion (MP) has been shown to improve heart preservation, we hypothesized that MP could enable the use of DCD hearts for transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom